Novavax Shares Slump After 2Q Revenue Misses Estimate

Signage at a Novavax facility in Gaithersburg, Maryland, US, on Monday, Aug. 26, 2024. Novavax shares earlier this month dropped 14% in premarket trading after the vaccine-maker reported revenue for the second quarter that missed the average analyst estimate and updated its guidance for the year. Photographer: Graeme Sloan/Bloomberg via Getty Images
Signage at a Novavax facility in Gaithersburg, Maryland, US, on Monday, Aug. 26, 2024. Novavax shares earlier this month dropped 14% in premarket trading after the vaccine-maker reported revenue for the second quarter that missed the average analyst estimate and updated its guidance for the year. Photographer: Graeme Sloan/Bloomberg via Getty Images
Novavax Shares Slump After 2Q Revenue Misses Estimate
PURCHASE A LICENCE
How can I use this image?
£275.00
GBP
Getty ImagesNovavax Shares Slump After 2Q Revenue Misses Estimate, News PhotoNovavax Shares Slump After 2Q Revenue Misses Estimate, News PhotoNovavax Shares Slump After 2Q Revenue Misses Estimate Get premium, high resolution news photos at Getty ImagesProduct #:2167893344
£375£150
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
2167893344
Collection:
Bloomberg
Date created:
26 August, 2024
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
NOVOVAX SHARES
Max file size:
4000 x 2666 px (33.87 x 22.57 cm) - 300 dpi - 6 MB